A triple stain of reticulin, glypican-3, and glutamine synthetase: A useful aid in the diagnosis of liver lesions

Benjamin J. Swanson, Martha M. Yearsley, William Marsh, Wendy L. Frankel

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Context.-The correct histologic diagnosis of mass lesions of the liver can be difficult, especially in biopsy samples. Reticulin, glypican-3, and glutamine synthetase are stains that can help distinguish hepatocellular carcinoma, hepatic adenoma, and focal nodular hyperplasia. Objective.-To evaluate the utility of a triple stain of reticulin, glypican-3, and glutamine synthetase in distinguishing hepatocellular carcinoma, hepatic adenoma, and focal nodular hyperplasia. Design.-Whole tissue sections and tissue microarrays were evaluated with a triple stain of reticulin, followed by glutamine synthetase (diaminobenzidine, brown chromogen) and glypican-3 (alkaline phosphatase, red chromogen). The 109 cases evaluated included whole tissue section hepatocellular carcinoma (n = 16), tissue microarray hepatocellular carcinoma (n = 19), whole tissue section hepatic adenoma (n = 15), tissue microarray hepatic adenoma (n = 13), whole tissue section focal nodular hyperplasia (n = 13; 12%), tissue microarray focal nodular hyperplasia (n = 13), as well as nonmalignant liver parenchyma adjacent to hepatocellular carcinoma (n = 20). All cases were scored for reticulin being intact or lost, positive or negative staining for glypican-3, and diffuse, maplike, perivenular, or negative staining for glutamine synthetase. Results.-The combination of intact reticulin with either glypican-3 negativity or negative glutamine synthetase was 92% sensitive and 95% specific in the distinction of tissue microarray hepatic adenoma from hepatocellular carcinoma. For the distinction of tissue microarray focal nodular hyperplasia and hepatic adenoma, maplike glutamine synthetase was most useful and was 85% sensitive and 100% specific. Conclusions.-The triple stain of reticulin, glypican-3, and glutamine synthetase is useful in the differentiation of hepatocellular carcinoma, hepatic adenoma, and focal nodular hyperplasia on biopsy specimens. Furthermore, this triple stain is advantageous to single stains and can help when aberrant staining patterns are observed.

Original languageEnglish (US)
Pages (from-to)537-542
Number of pages6
JournalArchives of Pathology and Laboratory Medicine
Volume139
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

Glypicans
Reticulin
Glutamate-Ammonia Ligase
Focal Nodular Hyperplasia
Coloring Agents
Adenoma
Hepatocellular Carcinoma
Liver
Negative Staining
Biopsy
Alkaline Phosphatase

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

A triple stain of reticulin, glypican-3, and glutamine synthetase : A useful aid in the diagnosis of liver lesions. / Swanson, Benjamin J.; Yearsley, Martha M.; Marsh, William; Frankel, Wendy L.

In: Archives of Pathology and Laboratory Medicine, Vol. 139, No. 4, 01.04.2015, p. 537-542.

Research output: Contribution to journalArticle

@article{dd941bb69d0b4c0bb9cf53e079cd98b1,
title = "A triple stain of reticulin, glypican-3, and glutamine synthetase: A useful aid in the diagnosis of liver lesions",
abstract = "Context.-The correct histologic diagnosis of mass lesions of the liver can be difficult, especially in biopsy samples. Reticulin, glypican-3, and glutamine synthetase are stains that can help distinguish hepatocellular carcinoma, hepatic adenoma, and focal nodular hyperplasia. Objective.-To evaluate the utility of a triple stain of reticulin, glypican-3, and glutamine synthetase in distinguishing hepatocellular carcinoma, hepatic adenoma, and focal nodular hyperplasia. Design.-Whole tissue sections and tissue microarrays were evaluated with a triple stain of reticulin, followed by glutamine synthetase (diaminobenzidine, brown chromogen) and glypican-3 (alkaline phosphatase, red chromogen). The 109 cases evaluated included whole tissue section hepatocellular carcinoma (n = 16), tissue microarray hepatocellular carcinoma (n = 19), whole tissue section hepatic adenoma (n = 15), tissue microarray hepatic adenoma (n = 13), whole tissue section focal nodular hyperplasia (n = 13; 12{\%}), tissue microarray focal nodular hyperplasia (n = 13), as well as nonmalignant liver parenchyma adjacent to hepatocellular carcinoma (n = 20). All cases were scored for reticulin being intact or lost, positive or negative staining for glypican-3, and diffuse, maplike, perivenular, or negative staining for glutamine synthetase. Results.-The combination of intact reticulin with either glypican-3 negativity or negative glutamine synthetase was 92{\%} sensitive and 95{\%} specific in the distinction of tissue microarray hepatic adenoma from hepatocellular carcinoma. For the distinction of tissue microarray focal nodular hyperplasia and hepatic adenoma, maplike glutamine synthetase was most useful and was 85{\%} sensitive and 100{\%} specific. Conclusions.-The triple stain of reticulin, glypican-3, and glutamine synthetase is useful in the differentiation of hepatocellular carcinoma, hepatic adenoma, and focal nodular hyperplasia on biopsy specimens. Furthermore, this triple stain is advantageous to single stains and can help when aberrant staining patterns are observed.",
author = "Swanson, {Benjamin J.} and Yearsley, {Martha M.} and William Marsh and Frankel, {Wendy L.}",
year = "2015",
month = "4",
day = "1",
doi = "10.5858/arpa.2013-0645-OA",
language = "English (US)",
volume = "139",
pages = "537--542",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "4",

}

TY - JOUR

T1 - A triple stain of reticulin, glypican-3, and glutamine synthetase

T2 - A useful aid in the diagnosis of liver lesions

AU - Swanson, Benjamin J.

AU - Yearsley, Martha M.

AU - Marsh, William

AU - Frankel, Wendy L.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Context.-The correct histologic diagnosis of mass lesions of the liver can be difficult, especially in biopsy samples. Reticulin, glypican-3, and glutamine synthetase are stains that can help distinguish hepatocellular carcinoma, hepatic adenoma, and focal nodular hyperplasia. Objective.-To evaluate the utility of a triple stain of reticulin, glypican-3, and glutamine synthetase in distinguishing hepatocellular carcinoma, hepatic adenoma, and focal nodular hyperplasia. Design.-Whole tissue sections and tissue microarrays were evaluated with a triple stain of reticulin, followed by glutamine synthetase (diaminobenzidine, brown chromogen) and glypican-3 (alkaline phosphatase, red chromogen). The 109 cases evaluated included whole tissue section hepatocellular carcinoma (n = 16), tissue microarray hepatocellular carcinoma (n = 19), whole tissue section hepatic adenoma (n = 15), tissue microarray hepatic adenoma (n = 13), whole tissue section focal nodular hyperplasia (n = 13; 12%), tissue microarray focal nodular hyperplasia (n = 13), as well as nonmalignant liver parenchyma adjacent to hepatocellular carcinoma (n = 20). All cases were scored for reticulin being intact or lost, positive or negative staining for glypican-3, and diffuse, maplike, perivenular, or negative staining for glutamine synthetase. Results.-The combination of intact reticulin with either glypican-3 negativity or negative glutamine synthetase was 92% sensitive and 95% specific in the distinction of tissue microarray hepatic adenoma from hepatocellular carcinoma. For the distinction of tissue microarray focal nodular hyperplasia and hepatic adenoma, maplike glutamine synthetase was most useful and was 85% sensitive and 100% specific. Conclusions.-The triple stain of reticulin, glypican-3, and glutamine synthetase is useful in the differentiation of hepatocellular carcinoma, hepatic adenoma, and focal nodular hyperplasia on biopsy specimens. Furthermore, this triple stain is advantageous to single stains and can help when aberrant staining patterns are observed.

AB - Context.-The correct histologic diagnosis of mass lesions of the liver can be difficult, especially in biopsy samples. Reticulin, glypican-3, and glutamine synthetase are stains that can help distinguish hepatocellular carcinoma, hepatic adenoma, and focal nodular hyperplasia. Objective.-To evaluate the utility of a triple stain of reticulin, glypican-3, and glutamine synthetase in distinguishing hepatocellular carcinoma, hepatic adenoma, and focal nodular hyperplasia. Design.-Whole tissue sections and tissue microarrays were evaluated with a triple stain of reticulin, followed by glutamine synthetase (diaminobenzidine, brown chromogen) and glypican-3 (alkaline phosphatase, red chromogen). The 109 cases evaluated included whole tissue section hepatocellular carcinoma (n = 16), tissue microarray hepatocellular carcinoma (n = 19), whole tissue section hepatic adenoma (n = 15), tissue microarray hepatic adenoma (n = 13), whole tissue section focal nodular hyperplasia (n = 13; 12%), tissue microarray focal nodular hyperplasia (n = 13), as well as nonmalignant liver parenchyma adjacent to hepatocellular carcinoma (n = 20). All cases were scored for reticulin being intact or lost, positive or negative staining for glypican-3, and diffuse, maplike, perivenular, or negative staining for glutamine synthetase. Results.-The combination of intact reticulin with either glypican-3 negativity or negative glutamine synthetase was 92% sensitive and 95% specific in the distinction of tissue microarray hepatic adenoma from hepatocellular carcinoma. For the distinction of tissue microarray focal nodular hyperplasia and hepatic adenoma, maplike glutamine synthetase was most useful and was 85% sensitive and 100% specific. Conclusions.-The triple stain of reticulin, glypican-3, and glutamine synthetase is useful in the differentiation of hepatocellular carcinoma, hepatic adenoma, and focal nodular hyperplasia on biopsy specimens. Furthermore, this triple stain is advantageous to single stains and can help when aberrant staining patterns are observed.

UR - http://www.scopus.com/inward/record.url?scp=84926373774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926373774&partnerID=8YFLogxK

U2 - 10.5858/arpa.2013-0645-OA

DO - 10.5858/arpa.2013-0645-OA

M3 - Article

C2 - 25822763

AN - SCOPUS:84926373774

VL - 139

SP - 537

EP - 542

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 4

ER -